Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

4G Clinical

Explore full profile

A leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural…

Wellesley, United StatesFounded 2015Marketing
Valuation $10–25M Last recorded · 2016
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for 4G Clinical and the history behind them.

About 4G Clinical

4G Clinical is a specialized company focused on enhancing the efficiency and effectiveness of clinical trials through advanced Randomization and Trial Supply Management (RTSM) solutions. The company serves pharmaceutical and biotechnology firms, providing them with tools to manage complex clinical trial designs and streamline global supply strategies. Operating in the healthcare and life sciences market, 4G Clinical's business model revolves around offering software solutions that predict demand, minimize waste, and ensure timely delivery of crucial medicines. Revenue is generated through subscription-based services and customized solutions tailored to the unique needs of each client. The company's flagship product, Prancer RTSM, supports everything from early-phase trials to highly complex studies, allowing for rapid iteration and approval of system specifications. By leveraging modern technology, 4G Clinical helps clinical supply managers surface risks, project patient demand, and adapt to protocol amendments, ultimately enhancing the safety and efficiency of clinical trials.

Source: Dealroom company data

At a glance

Founded
2015
Headquarters
Wellesley, United States
Sector
Marketing
Power Law
Colt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning 4G Clinical.

See all news

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Schooner Capital
  • Migration Capital

Series B and later1 investor entered at this stage

Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
13 countries with
team presence
🇺🇸 United States59.8%
🇬🇧 United Kingdom15.3%
🇮🇪 Ireland8.6%
🇯🇵 Japan5.5%
🇧🇪 Belgium3.7%
Top 5 of 13 shown
Web traffic by country
43K monthly visits
across markets
🇺🇸 United States66.3%
🇯🇵 Japan15.3%
🇧🇷 Brazil4.7%
🇰🇪 Kenya4.7%
🇦🇷 Argentina2.3%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about 4G Clinical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See 4G Clinical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.